ScholarLens Back to search
2007•Journal of Medical ForumRequires access

Effect of Acarbose and Metformin on Patients with Impaired Glucose Tolerance

Hongxia Lu

Open publisher page 0 citations

Abstract

Objective To observe the effect of acarbose and metformin on patients with impaired glucose tolerance(IGT).Methods Tofal 82 patients with IGT were randomly divided into two groups(acarbose group and metformin group).Acarbose group took acarbose 50~100mg,three times per day.Metformin group took metformin 250~500mg,three times per day.The study lasted for 12 months.Deteminating FPG、2hPG、TC、TG and HDL before and after the study.Results Both FPG and 2hPG significantly decreased in two groups(P0.05 and P0.01).But 2hPG significantly decreased in acarbose group compaired with that of metformin group(P0.01).TC、TG significantly decreased and HDL significantly increased in two groups,but there were no significant difference in two group.Metformin group can significantly decreased BMI compaired with acarbose group(P0.05).Conclusion Acarbose and metformin can be used to treat IGT patients.

About this research paper

What this paper is about

Objective To observe the effect of acarbose and metformin on patients with impaired glucose tolerance(IGT).Methods Tofal 82 patients with IGT were randomly divided into two groups(acarbose group and metformin group).Acarbose group took acarbose 50~100mg,three times per day.Metformin group took metformin 250~500mg,three times per day.The study lasted for 12 months.Deteminating FPG、2hPG、TC、TG and HDL before and after the study.Results Both FPG and 2hPG significantly decreased in two groups(P0.05 and P0.01).But 2hPG significantly decreased in acarbose group compaired with that of metformin group(P0.01).TC、TG significantly decreased and HDL significantly increased in two groups,but there were no significant difference in two group.Metformin group can significantly decreased BMI compaired with acarbose group(P0.05).Conclusion Acarbose and metformin can be used to treat IGT patients.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the effect of acarbose and metformin on patients with impaired glucose tolerance(IGT).Methods Tofal 82 patients with IGT were randomly divided into two groups(acarbose group and metformin group).Acarbose group took acarbose 50~100mg,three times per day.Metformin group took metformin 250~500mg,three times per day.The study lasted for 12 months.Deteminating FPG、2hPG、TC、TG and HDL before and after the study.Results Both FPG and 2hPG significantly decreased in two groups(P0.05 and P0.01).But 2hPG significantly decreased in acarbose group compaired with that of metformin group(P0.01).TC、TG significantly decreased and HDL significantly increased in two groups,but there were no significant difference in two group.Metformin group can significantly decreased BMI compaired with acarbose group(P0.05).Conclusion Acarbose and metformin can be used to treat IGT patients.

Key concepts: Acarbose, Metformin, Impaired glucose tolerance, Internal medicine, Medicine, Endocrinology, Diabetes mellitus, Type 2 diabetes

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Effect of Acarbose and Metformin on Patients with Impaired Glucose Tolerance — Research Paper | ScholarLens